Amneal Pharmaceuticals, Inc. (AMRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 16.21 |
| Open | 16.33 |
| Day High | 16.4 |
| Day Low | 16.02 |
| 52-Week High | 16.61 |
| 52-Week Low | 7.67 |
| Volume | 1.71M |
| Average Volume | 1.71M |
| Market Cap | 5.14B |
| PE | 43.54 |
| EPS | 0.37 |
| Moving Average 50 Days | 13.42 |
| Moving Average 200 Days | 12.42 |
| Change | -0.1 |
Amneal to Participate in Upcoming Investor Conference
GlobeNewswire Inc.
Mar 05, 2026 9:05 PM GMT
BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat at the following upcoming investor conference
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
GlobeNewswire Inc.
Jan 28, 2026 9:05 PM GMT
BRIDGEWATER, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has been added to the S&P SmallCap 600® Index. The inclusion will become effective prior to the ope
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
GlobeNewswire Inc.
Jan 27, 2026 1:00 PM GMT
BRIDGEWATER, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February